Free Newsletter
Gene combo dramatically increases risk of Alzheimer's
New work at the Translational Genomics Research Institute in Phoenix has revealed that a copy of the APOE4 gene variant quadruples a person's chances of developing late-onset Alzheimer's. Couple that with the GAB2 variant and the chance of developing the disease rises to 16 times the average risk factor. The scientists believe that the combination of the two spurs the development of one of the proteins that afflicts the brains of people with Alzheimer's. In their work, the scientists screened the DNA of 1400 people, half of whom had the disease.
- here's the report from China Post
ALSO: The latest worldwide estimate of Alzheimer's prevalence shows that 26.6 million people were living with the disease in 2006. That number is expected to quadruple by 2050. Report
Related Articles:
Gene abnormality linked to Alzheimer's. Report
Enzyme essential to preventing Alzheimer's. Report
BRNI discovery raises hopes for Alzheimer's test. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
